85 related articles for article (PubMed ID: 22204740)
1. Synthesis and evaluation of novel modified γ-lactam prostanoids as EP4 subtype-selective agonists.
Kambe T; Maruyama T; Nagase T; Ogawa S; Minamoto C; Sakata K; Maruyama T; Nakai H; Toda M
Bioorg Med Chem; 2012 Jan; 20(2):702-13. PubMed ID: 22204740
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of γ-lactam analogs of PGE₂ as EP4 and EP2/EP4 agonists.
Kambe T; Maruyama T; Nakai Y; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
Bioorg Med Chem; 2012 Jun; 20(11):3502-22. PubMed ID: 22546206
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.
Kambe T; Maruyama T; Nakai Y; Yoshida H; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
Bioorg Med Chem; 2012 Apr; 20(7):2235-51. PubMed ID: 22386979
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.
Kambe T; Maruyama T; Nakano M; Nakai Y; Yoshida T; Matsunaga N; Oida H; Konaka A; Maruyama T; Nakai H; Toda M
Bioorg Med Chem Lett; 2012 Jan; 22(1):396-401. PubMed ID: 22119471
[TBL] [Abstract][Full Text] [Related]
5. Discovery of orally available 8-aza-5-thiaProstaglandin E1 analogs as highly selective EP4 agonists.
Kambe T; Maruyama T; Nakano M; Yamaura Y; Shono T; Seki A; Sakata K; Maruyama T; Nakai H; Toda M
Chem Pharm Bull (Tokyo); 2011; 59(12):1523-34. PubMed ID: 22130375
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.
Arns S; Gibe R; Moreau A; Monzur Morshed M; Young RN
Bioorg Med Chem; 2012 Mar; 20(6):2131-40. PubMed ID: 22341574
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a gamma-lactam as a highly selective EP2 and EP4 receptor agonist.
Xiao Y; Araldi GL; Zhao Z; Reddy A; Karra S; Brugger N; Fischer D; Palmer E; Bao B; McKenna SD
Bioorg Med Chem Lett; 2008 Jan; 18(2):821-4. PubMed ID: 18039575
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
[TBL] [Abstract][Full Text] [Related]
9. Lactams as prostanoid receptor ligands. Part 4: 2-Piperidones as selective EP4 receptor agonists.
Elworthy TR; Brill ER; Caires CC; Kim W; Lach LK; Tracy JL; Chiou SS
Bioorg Med Chem Lett; 2005 May; 15(10):2523-6. PubMed ID: 15863309
[TBL] [Abstract][Full Text] [Related]
10. Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization.
Elworthy TR; Kertesz DJ; Kim W; Roepel MG; Quattrocchio-Setti L; Smith DB; Tracy JL; Chow A; Li F; Brill ER; Lach LK; McGee D; Yang DS; Chiou SS
Bioorg Med Chem Lett; 2004 Apr; 14(7):1655-9. PubMed ID: 15026044
[TBL] [Abstract][Full Text] [Related]
11. Efficient synthesis of a novel m-phenylene derivative as a selective EP4 agonist inducing follicular growth and maturation in the ovary.
Hayashi R; Hosono Y; Nakatsuji K; Tanaka Y; Mori T; Kanno T; Makita K; Moriwaki M; Ohyama T; Ochi Y; Inada C; Isogaya M
Bioorg Med Chem Lett; 2011 Dec; 21(24):7505-8. PubMed ID: 22061638
[TBL] [Abstract][Full Text] [Related]
12. Discovery of an 8-aza-5-thiaProstaglandin E1 analog as a highly selective EP4 receptor agonist.
Kambe T; Maruyama T; Naganawa A; Asada M; Seki A; Maruyama T; Nakai H; Toda M
Chem Pharm Bull (Tokyo); 2011; 59(12):1494-508. PubMed ID: 22130372
[TBL] [Abstract][Full Text] [Related]
13. Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP
Healy MP; Allan AC; Bailey K; Billinton A; Chessell IP; Clayton NM; Giblin GMP; Kay MA; Khaznadar T; Michel AD; Naylor A; Price H; Spalding DJ; Stevens DA; Swarbrick ME; Wilson AW
Bioorg Med Chem Lett; 2018 Jun; 28(10):1892-1896. PubMed ID: 29636218
[TBL] [Abstract][Full Text] [Related]
14. Lactams as EP4 prostanoid receptor agonists. 3. Discovery of N-ethylbenzoic acid 2-pyrrolidinones as subtype selective agents.
Elworthy TR; Brill ER; Chiou SS; Chu F; Harris JR; Hendricks RT; Huang J; Kim W; Lach LK; Mirzadegan T; Yee C; Walker KA
J Med Chem; 2004 Dec; 47(25):6124-7. PubMed ID: 15566283
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model.
Cruz Duarte P; St-Jacques B; Ma W
Exp Neurol; 2012 Apr; 234(2):466-81. PubMed ID: 22309829
[TBL] [Abstract][Full Text] [Related]
16. Difluoromethylene at the γ-Lactam α-Position Improves 11-Deoxy-8-aza-PGE
Barrett SD; Holt MC; Kramer JB; Germain B; Ho CS; Ciske FL; Kornilov A; Colombo JM; Uzieblo A; O'Malley JP; Owen TA; Stein AJ; Morano MI
J Med Chem; 2019 May; 62(9):4731-4741. PubMed ID: 30964292
[TBL] [Abstract][Full Text] [Related]
17. Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor.
Burch JD; Farand J; Colucci J; Sturino C; Ducharme Y; Friesen RW; Lévesque JF; Gagné S; Wrona M; Therien AG; Mathieu MC; Denis D; Vigneault E; Xu D; Clark P; Rowland S; Han Y
Bioorg Med Chem Lett; 2011 Feb; 21(3):1041-6. PubMed ID: 21215624
[TBL] [Abstract][Full Text] [Related]
18. Discovery and characterization of a potent and selective EP4 receptor antagonist.
Schiffler MA; Chandrasekhar S; Fisher MJ; Harvey A; Kuklish SL; Wang XS; Warshawsky AM; York JS; Yu XP
Bioorg Med Chem Lett; 2015 Aug; 25(16):3176-8. PubMed ID: 26091726
[TBL] [Abstract][Full Text] [Related]
19. Novel pyridone EP
Dorich S; Cox JH; Burch JD; Chagnon F; Chen B; Léger S; St-Onge M; Fader LD
Bioorg Med Chem Lett; 2020 May; 30(10):127104. PubMed ID: 32201020
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.
Jiang GL; Im WB; Donde Y; Wheeler LA
J Pharmacol Exp Ther; 2010 Dec; 335(3):546-52. PubMed ID: 20833794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
